Possis Medical, Inc. (NASDAQ-NMS: POSS) a developer, manufacturer and distributor of pioneering medical devices used in endovascular procedures, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market its AngioJet® Spiroflex® rapid exchange catheter to remove blood clots (thrombus) from coronary arteries. [click link for full article]
More...